SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Lupus
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Sebastiani, G D
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sebastiani, G D
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH
Medline Plus Health Information
*Lupus
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

HLA-DPB1 alleles association of anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with systemic lupus erythematosus

G D Sebastiani

UO Complessa di Reumatologia, Azienda Ospedaliera San Camillo-Forlanini, Roma, Italy, gsebastiani{at}scamilloforlanini.rm.it

M Galeazzi

Istituto di Reumatologia, Universita di Siena, Siena, Italy

A Tincani

Servizio di Immunologia Clinica, Spedali Civili, Brescia, Italy

R Scorza

Istituto di Medicina Interna, Malattie Infettive e Immunopatologia, Universita di Milano, Milano, Italy

A Mathieu

II Cattedra di Reumatologia, Universita di Cagliari, Cagliari, Italy

G Passiu

II Cattedra di Reumatologia, Universita di Cagliari, Cagliari, Italy

G Morozzi

Istituto di Reumatologia, Universita di Siena, Siena, Italy

J C Piette

Service Medecine Interne, CHU Pitie-Salpetriere, Paris, France

R Cervera

Unitat de Malalties Autoimmunes Sistemiques, Hospital Clinic, Barcelona, Spain

F Houssiau

Service du Rhumatologie, Universite Catholique de Louvain, Bruxelles, Belgium

J Smolen

Department of Medicine, Lainz Hospital, Vienna, Austria

A Fernandez Nebro

Hospital and University of Malaga, Malaga, Spain

E De Ramon

Hospital and University of Malaga, Malaga, Spain

A Jedryka Goral

Institute of Rheumatology, Warsaw, Poland

C Papasteriades

Evangelismos Hospital, Athens, Greece

G B Ferrara

Centro Biotecnologie Avanzate, Genova, Italy

C Carcassi

Dipartimento Genetica Medica, Universitàdi Cagliari, Cagliari, Italy

F Bellisai

Istituto di Reumatologia, Universita di Siena, Siena, Italy

R Marcolongo

Istituto di Reumatologia, Universita di Siena, Siena, Italy

European Concerted Action on Immunogenetics of SLE

Our objective was to determine the HLA-DPB1 allele associations of anticardiolipin (aCL) and anti-beta2 GPI (aß2 GPI) antibodies, and of clinical manifestations of the antiphospholipid syndrome (APS), in systemic lupus erythematosus(SLE). We studied 577 European patients with SLE. aCL and aß2 GPI antibodies were measured by ELISA. Molecular typing of HLA-DPB1 locus was performed by polymerase chain reaction-sequence specific oligonucleotide probe (PCR-SSOP) method. aCL showed positive association with -DPB1*1501 (P 0.005, OR 7.4), and -DPB1*2301 (P 0.009, OR 3.3). aß2 GPI showed positive association with -DPB1*0301 (P 0.01, OR 1.9), and -DPB1*1901 (P 0.004, OR 8.1). In addition, livedo reticularis was associated with -DPB1*1401, and Raynaud’s phenomenon with -DPB1*2001. In conclusion, HLA-DPB1 locus may contribute to the genetic predisposition to develop antiphospholipid antibodies and clinical manifestations of the APS in patients with SLE.

Key Words: anti-ß2 GPI antibodies • anticardiolipin antibodies • antiphospholipid syndrome • HLA • HLA-DPB1 locus • systemic lupus erythematosus

Lupus, Vol. 12, No. 7, 560-563 (2003)
DOI: 10.1191/0961203303lu402oa


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J Intensive Care MedHome page
S. K. Vora, R. A. Asherson, and D. Erkan
Catastrophic Antiphospholipid Syndrome
J Intensive Care Med, May 1, 2006; 21(3): 144 - 159.
[Abstract] [PDF]


Home page
Ann Rheum DisHome page
I Uthman and M Khamashta
Ethnic and geographical variation in antiphospholipid (Hughes) syndrome
Ann Rheum Dis, December 1, 2005; 64(12): 1671 - 1676.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
M V. Freitas, L M da Silva, N H. Deghaide, E A Donadi, and P Louzada-Junior
Is HLA class II susceptibility to primary antiphospholipid syndrome different from susceptibility to secondary antiphospholipid syndrome?
Lupus, February 1, 2004; 13(2): 125 - 131.
[Abstract] [PDF]



Advertisement